Moxibustion at CV4 alleviates atherosclerotic lesions through activation of the LXR α/ABCA1 pathway in apolipoprotein-E-deficient mice.

CONCLUSION: Moxibustion treatment at CV4 suppressed the progression of atherosclerotic lesions in ApoE-/- mice. The anti-atherogenic effect of moxibustion may be achieved by: (1) regulation of lipid metabolism, and thus prevention of lipid accumulation; and (2) upregulation of LXRα- and ABCA1-mediated cholesterol efflux in the lesion area.
PMID: 31140825 [PubMed - as supplied by publisher]

Source: Acupuncture in Medicine : journal of the British Medical Acupuncture Society - May 28, 2019 Category: Complementary Medicine Authors: Cui Y, Liu J, Huang C, Zhao B Tags: Acupunct Med Source Type: research